Global Outbreak Intelligence
Real-time aggregation of WHO, CDC and ECDC outbreak notifications. Tap an outbreak to see every active location on the map — tap a dot for full intelligence.
No current outbreak poses elevated risk to the general European population. Mpox Clade Ib in Europe is the primary emerging concern — check vaccine status if in high-risk groups.
Risk varies by destination. Bangladesh (measles), Ecuador (yellow fever), South American cruise routes (hantavirus) all carry specific active risks. Verify vaccinations 6–8 weeks before departure.
H5N1 occupational risk is real for poultry and dairy workers. Use PPE. Report sick animals immediately.
H5N1 on all major preparedness watchlists. No current pathogen has acquired the lethality + H2H spread combination required for a COVID-scale event.
Deep-tier threat signals, risk matrices and preparedness checklists at GlobalContagion.com
EBOLA BUNDIBUGYO PHEIC · DRC & Uganda. 543 suspected cases, 131+ deaths. WHO PHEIC declared 16 May 2026. No approved vaccine or treatment. CDC Level 3 DRC, Level 1 Uganda.
20 May 2026HANTAVIRUS · MV Hondius disembarkation complete in Tenerife. 16 US passengers at UNMC biocontainment. WHO DG: "This is not another COVID." Global risk: LOW.
12 May 2026MPOX CLADE Ib · Local transmission confirmed Denmark. UK: 48 cases as of 30 Apr. Novel recombinant Clade Ib/IIb strain under characterisation. ECDC risk: MODERATE.
7 May 2026H5N1 · No new US human cases since Feb 2025. 71 total. Virus persists in dairy cattle 18+ states. CDC routine surveillance active. General public risk: LOW.
29 Apr 2026MEASLES · Bangladesh 47,260 cases, 259 deaths in 2026. WHO emergency vaccination underway. Travellers: verify 2-dose MMR before departure.
5 May 2026